Skip to main content

Together we are beating cancer

Donate now

Precancerous conditions

Showing 11 out of 11 results
A microscope image showing cells affected by Barrett's oesophagus, a precancer that can lead to oesophageal cancer.

For oesophageal cancer awareness month, we’ve rounded up four of our articles on the latest research into oesophageal cancer diagnosis, treatment and prevention.   For oesophageal cancer awareness month, we’ve rounded up four of our articles on the latest research into oesophageal cancer diagnosis, treatment and prevention.  

by Amy Warnock | Analysis | 9 February 2024

9 February 2024

An image of a capsule sponge, a test for Barrett's oesophagus and oesophageal cancer

Our BEST4 trial will show if a capsule sponge test can be used to monitor people at high risk of oesophageal cancer. It could give the NHS a quick and simple new screening test for oesophageal cancer and save thousands of lives every year.  Our BEST4 trial will show if a capsule sponge test can be used to monitor people at high risk of oesophageal cancer. It could give the NHS a quick and simple new screening test for oesophageal cancer and save thousands of lives every year. 

by Tim Gunn | Analysis | 11 January 2024

11 January 2024

Two cancer researchers looking at a cell image on screen

Each cancer is as unique as the person it affects. By studying patient data, we can target our treatments to people's specific needs. Each cancer is as unique as the person it affects. By studying patient data, we can target our treatments to people's specific needs.

by Cancer Research UK | In depth | 21 November 2023

21 November 2023

Cancer cells with extrachromosomal DNA (ecDNA)

Cancer Grand Challenges team eDyNAmiC has changed our understanding of how oesophageal cancer starts. In some cases, mutations scientists thought were a late effect of the disease could actually be driving it in the first place. The findings could give us a new way to intercept cancer before it becomes dangerous. Cancer Grand Challenges team eDyNAmiC has changed our understanding of how oesophageal cancer starts. In some cases, mutations scientists thought were a late effect of the disease could actually be driving it in the first place. The findings could give us a new way to intercept cancer before it becomes dangerous.

by Tim Gunn | In depth | 23 October 2023

23 October 2023

Doctor reviewing a mammogram

New research may have found a way we can predict which cases of DCIS could develop into invasive breast cancer and thus require treatment, reducing the burden of overtreatment in future New research may have found a way we can predict which cases of DCIS could develop into invasive breast cancer and thus require treatment, reducing the burden of overtreatment in future

by Jacob Smith | Analysis | 20 June 2023

20 June 2023

Cancer Research UK logo

UK scientists have discovered the genetic basis for why some people are more at risk of developing Barrett's oesophagus, a condition that increases the risk of oesophageal cancer. UK scientists have discovered the genetic basis for why some people are more at risk of developing Barrett's oesophagus, a condition that increases the risk of oesophageal cancer.

by In collaboration with PA Media Group | News | 10 September 2012

10 September 2012

Cancer Research UK logo

In the largest study of its kind, Danish researchers have found that the rates of oesophageal cancer among people with Barrett's oesophagus - a common condition that predisposes to the disease - could be up to four times lower than previous estimates. In the largest study of its kind, Danish researchers have found that the rates of oesophageal cancer among people with Barrett's oesophagus - a common condition that predisposes to the disease - could be up to four times lower than previous estimates.

by In collaboration with PA Media Group | News | 13 October 2011

13 October 2011

Cancer Research UK logo

CANCER RESEARCH UK scientists have found that blocking the pathway used by some kidney cancer cells to generate energy can kill the cancer cells, sparing the healthy ones. CANCER RESEARCH UK scientists have found that blocking the pathway used by some kidney cancer cells to generate energy can kill the cancer cells, sparing the healthy ones.

by Cancer Research UK | News | 17 August 2011

17 August 2011

Cancer Research UK logo

CANCER RESEARCH UK-funded scientists have shown that an early chemotherapy drug invented in the 1940s has the potential to work against a genetic fault called HNPCC* which is linked to bowel and other cancers. The results are published in EMBO Molecular Medicine** today, (Thursday). CANCER RESEARCH UK-funded scientists have shown that an early chemotherapy drug invented in the 1940s has the potential to work against a genetic fault called HNPCC* which is linked to bowel and other cancers. The results are published in EMBO Molecular Medicine** today, (Thursday).

by Cancer Research UK | News | 27 August 2009

27 August 2009

Cancer Research UK logo

NEW research in Yorkhill Hospital and Glasgow Royal Infirmary is investigating whether a form of the contraceptive coil can stop women from developing womb cancer. NEW research in Yorkhill Hospital and Glasgow Royal Infirmary is investigating whether a form of the contraceptive coil can stop women from developing womb cancer.

by Cancer Research UK | News | 10 June 2008

10 June 2008

Cancer Research UK logo

Bowel cancer rates could be reduced by up to 80 per cent in people with a moderate family history of the disease by screening with colonoscopy, according to new research published in the British Medical Journal. Bowel cancer rates could be reduced by up to 80 per cent in people with a moderate family history of the disease by screening with colonoscopy, according to new research published in the British Medical Journal.

by Cancer Research UK | News | 25 October 2005

25 October 2005